Dyskeratosis Congenita, also known as zinsser-engman-cole syndrome, is related to dyskeratosis congenita, x-linked and dyskeratosis congenita, autosomal dominant 1, and has symptoms including onychomadesis An important gene associated with Dyskeratosis Congenita is DKC1 (Dyskerin Pseudouridine Synthase 1), and among its related pathways/superpathways are Cell Cycle, Mitotic and Telomere C-strand (Lagging Strand) Synthesis. The drugs Fludarabine and Alemtuzumab have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and skin, and related phenotypes are anemia and abnormal fingernail morphology